A California plaintiff, who used Roundup on his 56-acre Santa Rosa property and alleged glyphosate caused his non-Hodgkin lymphoma, has been awarded $80 million by a jury in the U.S. District Court for the Northern District of California.  This verdict is the second significant glyphosate judgment against Bayer-owned Monsanto, following on the August 2018 verdict that awarded a former school groundskeeper $289 million (later reduced to $78 million by a judge reviewing the case). 

In a statement after the verdict, Bayer expressed disappointment but stressed that the science supports that its glyphosate products are not carcinogenic.  In particular, Bayer quoted a recent Health Canada statement that “no pesticide regulatory authority in the world currently considers glyphosate to be a cancer risk to humans at the levels at which humans are currently exposed.”

 Hundreds of additional cases are forthcoming, including a federal multi-district litigation scheduled to begin at the U.S. District Court for the Northern District of California on May 20, 2019.